A study by Tang et al. categorized CRC patients into four groups based on the expression signatures of cancer-associated fibroblasts, MDSCs, M2-like TAMs, CD8+ T cells, and PD-L1 expression and found that classification of CRC patients into immune subtypes was a reliable predictor of prognosis. Here, CD8A is linked to colorectal carcinoma.